Seraxis Inc News Today

Seraxis Manufacturing Suite Completes GMP Quality System Audit Ahead ...

Seraxis Announces Publication of Preclinical Data for a Novel Islet ...

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets fo...

Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate ...

Late-Breaking Results of a Preclinical Efficacy Study Presented at ...

Synthetic Replacement Endocrine (SRE) Clusters GERMANTOWN, Md., April 25, 2023 (Newswire.com) - Seraxis Inc., a pre-clinical stage company with a best-in-class islet replacement therapy for insulin-dependent diabetes, today announced the presentation of results from an ef...

Seraxis Presents Successful Results Using Synthetic Replacement Endocrine ...

Stem Cell Therapy Market Research Report Information By Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood-Derived, IPSCs, PPSCs), By

Chronic health conditions, including heart disease, neurological disorders, cancer, respiratory illnesses, stroke, and cardiovascular disorders, are...

/PRNewswire/ -- The regenerative medicine company Seraxis today announces that Shelley Hartman, Jerry Baty, and Min-Jung Choi are appointed to its Board of...